Charting co-mutation patterns associated with actionable drivers in intrahepatic cholangiocarcinoma
-
Published:2023-03
Issue:3
Volume:78
Page:614-626
-
ISSN:0168-8278
-
Container-title:Journal of Hepatology
-
language:en
-
Short-container-title:Journal of Hepatology
Author:
Kendre GajananORCID,
Murugesan KarthikeyanORCID,
Brummer TilmanORCID,
Segatto OresteORCID,
Saborowski Anna,
Vogel ArndtORCID
Reference33 articles.
1. Cholangiocarcinoma landscape in Europe: diagnostic, prognostic and therapeutic insights from the ENSCCA Registry;Izquierdo-Sanchez;J Hepatol,2022
2. Whole-genome and epigenomic landscapes of etiologically distinct subtypes of cholangiocarcinoma;Jusakul;Cancer Discov,2017
3. Pertuzumab plus trastuzumab for HER2-amplified metastatic colorectal cancer (MyPathway): an updated report from a multicentre, open-label, phase 2a, multiple basket study;Meric-Bernstam;Lancet Oncol,2019
4. Co-occurring genomic alterations define major subsets of KRAS-mutant lung adenocarcinoma with distinct biology, immune profiles, and therapeutic vulnerabilities;Skoulidis;Cancer Discov,2015
5. Systematic pan-cancer analysis of mutation-treatment interactions using large real-world clinicogenomics data;Liu;Nat Med,2022
Cited by
29 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献